1. Home
  2. SCKT vs INDP Comparison

SCKT vs INDP Comparison

Compare SCKT & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Socket Mobile Inc.

SCKT

Socket Mobile Inc.

HOLD

Current Price

$1.06

Market Cap

7.5M

Sector

Technology

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$2.05

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCKT
INDP
Founded
1992
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
4.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SCKT
INDP
Price
$1.06
$2.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
28.9K
39.0K
Earning Date
10-22-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,945,490.00
N/A
Revenue This Year
$8.62
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$1.65
52 Week High
$1.72
$47.60

Technical Indicators

Market Signals
Indicator
SCKT
INDP
Relative Strength Index (RSI) 37.56 39.79
Support Level $1.24 $2.39
Resistance Level $1.29 $2.94
Average True Range (ATR) 0.05 0.20
MACD -0.03 0.01
Stochastic Oscillator 9.93 11.39

Price Performance

Historical Comparison
SCKT
INDP

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: